Updates are available Correction dated 2025-06-24
Click to view Correction: https://doi.org/10.1186/s13058-025-02046-1
-
Authors
Ribas, Ricardo
Pancholi, Sunil
Rani, Aradhana
Schuster, Eugene
Guest, Stephanie K.
Nikitorowicz-Buniak, Joanna
Simigdala, Nikiana
Thornhill, Allan
Avogadri-Connors, Francesca
Cutler, Richard E. Jr
Lalani, Alshad S.
Dowsett, Mitch
Johnston, Stephen R.
Martin, Lesley-Ann https://orcid.org/0000-0002-7606-4161
-
Funding
Funding for this research was provided by:
Breast Cancer Now (CTR-Q3, CTR-Q3)
Puma Biotechnology
Arthur Foundation
Arthur Foundation
Royal Marsden NHS Foundation Trust
Royal Marsden NHS Foundation Trust
- License Information
-
More Information
Article History
Received: 22 January 2018
Accepted: 10 May 2018
First Online: 8 June 2018
Change Date: 24 June 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13058-025-02046-1
Ethics approval and consent to participate
: In-vivo studies were carried out in accordance with Home Office guidelines and approved by the Institute of Cancer Research Ethics Committee.
: All authors approved the final version of this manuscript.
: L-AM and SRJ receive academic funding from PUMA Biotechnology. FA-C, ASL, and REC are employees of PUMA Biotechnology. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
